$英特尔(INTC)$  芯片制造工厂的价值还没有被有效评估。

$Meta Platforms(META)$  等风 人工智能的未来在元宇宙

$艾吉纳斯公司(AGEN)$$安帝君斯(AGEN)$ MSS CRC取得的一点点小突破，下一代CTLA-4呼之欲出Study HighlightsA total of 41 evaluable patients with metastatic MSS CRC received either 1 or 2 mg/kg botensilimab Q6W, and 3 mg/kg balstilimab Q2W. Patients were heavily pre-treated, with a median of 4 prior lines of therapy, and 34% had received prior immunotherapy. The botensilimab/balstilimab combination produced superior responses and strong durability, relative to what has been reported in separate trials for standard of care and other combinations currently in development.Objective responses:24% overall response rate73% disease control rate (partial response + stable disease)50% objective responses with greater than 50% tumor reductionDurability:80% objective responses ongoing at data cu

$Synthetic Biologics Inc(SYN)$加

$Synthetic Biologics Inc(SYN)$别卖，没有量了。都是在送筹码

$Synthetic Biologics Inc(SYN)$等

$Synthetic Biologics Inc(SYN)$SYNTHETIC BIOLOGICS REGAINS COMPLIANCE WITH NYSE AMERICAN CONTINUED LISTING STANDARDS

$Synthetic Biologics Inc(SYN)$等

$Synthetic Biologics Inc(SYN)$等

$Synthetic Biologics Inc(SYN)$稳

$Synthetic Biologics Inc(SYN)$静待

$Synthetic Biologics Inc(SYN)$6.2

$Synthetic Biologics Inc(SYN)$稳住

$Synthetic Biologics Inc(SYN)$1.5 5.16 7.14 13.6

$Synthetic Biologics Inc(SYN)$老虎数据没更新啊，应该是 1.05亿股本。稳住，看到10亿。

$Synthetic Biologics Inc(SYN)$耐心等待

$Synthetic Biologics Inc(SYN)$看多

$Synthetic Biologics Inc(SYN)$看5

$Synthetic Biologics Inc(SYN)$等2.86